Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral Research Award: Canada Graduate Scholarships

McMaster University

$105,000.00

3D Microengineered Hydrogels for Enhanced Understanding of Pulmonary Fibrosis Mechanisms

EF 2023-24

Résumé
Lung fibrosis refers to the excessive scarring within the lung tissue, rendering it stiff and making breathing difficult. Presently, only two drugs have received approval for treating idiopathic pulmonary fibrosis (IPF)-a particularly aggressive form of lung fibrosis. While these drugs can slow down disease progression, they do not restore lung health and can come with serious side effects. Earlier drug developments for IPF primarily targeted cellular changes under the assumption that cells were the main contributors to disease progression. However, recent research has underscored the pivotal role played by the very material that makes up the scars in the progression of IPF. This progression is not necessarily tied to particular cell types but is more related to forces exerted when patients breathe. These forces can release molecules from the scars that directly intensify the disease. To foster the creation of innovative therapies, I aim to develop models that more accurately represent the scars implicated in disease progression and can inform new treatment avenues. This proposal's main objectives include (I) Designing and producing water-soluble gels (hydrogels) that help model lung fibrosis at various stages, (II) Evaluating these gels under stresses akin to those experienced by IPF patients during breathing, and (III) Assessing how FDA-approved drugs and other novel treatments affect fibrosis progression. These gels will be formulated from both non-IPF and IPF human lung decellularized extracellular matrices-serving as biochemical signals-and strengthened by a supplementary biomaterial for mechanical signals. A major advantage of this pioneering technique lies in its simple, cost-effective preparation relative to existing methods, all while presenting a more representative model of IPF useful for drug development. Moreover, this technology holds promise for modelling fibrosis in other organs, expanding its potential impact beyond lung diseases.
Programme
Doctoral Research Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
496429
Name
Dabaghi Mohammadhossein
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
3D Microengineered Hydrogels for Enhanced Understanding of Pulmonary Fibrosis Mechanisms
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Drug Development; Fibrosis; Hydrogels; Lung; Lung Models; Pulmonary
Abstract
Lung fibrosis refers to the excessive scarring within the lung tissue, rendering it stiff and making breathing difficult. Presently, only two drugs have received approval for treating idiopathic pulmonary fibrosis (IPF)-a particularly aggressive form of lung fibrosis. While these drugs can slow down disease progression, they do not restore lung health and can come with serious side effects. Earlier drug developments for IPF primarily targeted cellular changes under the assumption that cells were the main contributors to disease progression. However, recent research has underscored the pivotal role played by the very material that makes up the scars in the progression of IPF. This progression is not necessarily tied to particular cell types but is more related to forces exerted when patients breathe. These forces can release molecules from the scars that directly intensify the disease. To foster the creation of innovative therapies, I aim to develop models that more accurately represent the scars implicated in disease progression and can inform new treatment avenues. This proposal's main objectives include (I) Designing and producing water-soluble gels (hydrogels) that help model lung fibrosis at various stages, (II) Evaluating these gels under stresses akin to those experienced by IPF patients during breathing, and (III) Assessing how FDA-approved drugs and other novel treatments affect fibrosis progression. These gels will be formulated from both non-IPF and IPF human lung decellularized extracellular matrices-serving as biochemical signals-and strengthened by a supplementary biomaterial for mechanical signals. A major advantage of this pioneering technique lies in its simple, cost-effective preparation relative to existing methods, all while presenting a more representative model of IPF useful for drug development. Moreover, this technology holds promise for modelling fibrosis in other organs, expanding its potential impact beyond lung diseases.
Competitiondate
202311
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Dabaghi, Mohammadhossein
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~